OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV ‐2
Abhishek Gour, Diksha Manhas, Swarnendu Bag, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4258-4283
Open Access | Times Cited: 46
Abhishek Gour, Diksha Manhas, Swarnendu Bag, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4258-4283
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 125
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 125
Boosting the human antiviral response in conjunction with natural plant products
Rashmi Srivastava, Neeraj Kumar Dubey, Megha Sharma, et al.
Frontiers in Natural Products (2025) Vol. 3
Open Access | Times Cited: 1
Rashmi Srivastava, Neeraj Kumar Dubey, Megha Sharma, et al.
Frontiers in Natural Products (2025) Vol. 3
Open Access | Times Cited: 1
Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review
Mohammad Amin Khazeei Tabari, Amin Iranpanah, Roodabeh Bahramsoltani, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3900-3900
Open Access | Times Cited: 61
Mohammad Amin Khazeei Tabari, Amin Iranpanah, Roodabeh Bahramsoltani, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3900-3900
Open Access | Times Cited: 61
Anticancer, Anticoagulant, Antioxidant and Antimicrobial Activities of Thevetia peruviana Latex with Molecular Docking of Antimicrobial and Anticancer Activities
Aisha M. H. Al‐Rajhi, Reham Yahya, Tarek M. Abdelghany, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3165-3165
Open Access | Times Cited: 36
Aisha M. H. Al‐Rajhi, Reham Yahya, Tarek M. Abdelghany, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3165-3165
Open Access | Times Cited: 36
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions
Ludmila Müller, Svetlana Di Benedetto
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 21
Ludmila Müller, Svetlana Di Benedetto
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 21
Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways
Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1533-1539
Open Access | Times Cited: 34
Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1533-1539
Open Access | Times Cited: 34
Ginkgo biloba in the management of the COVID‐19 severity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Open Access | Times Cited: 27
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Open Access | Times Cited: 27
Immunoprotective effect of silybin through blocking p53-driven caspase-9-Apaf-1-Cyt c complex formation and immune dysfunction after difenoconazole exposure in carp spleen
Enzhuang Pan, Xin Yue, Xueqing Li, et al.
Environmental Science and Pollution Research (2024) Vol. 31, Iss. 13, pp. 19396-19408
Closed Access | Times Cited: 5
Enzhuang Pan, Xin Yue, Xueqing Li, et al.
Environmental Science and Pollution Research (2024) Vol. 31, Iss. 13, pp. 19396-19408
Closed Access | Times Cited: 5
Nanotechnology Applications of Flavonoids for Viral Diseases
Khoshnur Jannat, Alok Kumar Paul, Tohmina Afroze Bondhon, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1895-1895
Open Access | Times Cited: 33
Khoshnur Jannat, Alok Kumar Paul, Tohmina Afroze Bondhon, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1895-1895
Open Access | Times Cited: 33
Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials
Jia Yao, Yuan Zhang, Xian-Zhe Wang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 22
Jia Yao, Yuan Zhang, Xian-Zhe Wang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 22
Therapeutic and prophylactic effect of flavonoids inpost‐COVID‐19 therapy
Annamária Bardelčíková, A. Miroššay, Jindřich Šoltýs, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 5, pp. 2042-2060
Open Access | Times Cited: 21
Annamária Bardelčíková, A. Miroššay, Jindřich Šoltýs, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 5, pp. 2042-2060
Open Access | Times Cited: 21
Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a mechanistic review
Ibrahim Jantan, Nor Azrina Norahmad, Yuandani Yuandani, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-26
Closed Access | Times Cited: 3
Ibrahim Jantan, Nor Azrina Norahmad, Yuandani Yuandani, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-26
Closed Access | Times Cited: 3
Innovative Processing Technologies to Develop a New Segment of Functional Citrus-Based Beverages: Current and Future Trends
Ana A. Vilas-Boas, Daniela Magalhães, Débora A. Campos, et al.
Foods (2022) Vol. 11, Iss. 23, pp. 3859-3859
Open Access | Times Cited: 20
Ana A. Vilas-Boas, Daniela Magalhães, Débora A. Campos, et al.
Foods (2022) Vol. 11, Iss. 23, pp. 3859-3859
Open Access | Times Cited: 20
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Management of Mild-to-Moderate Symptomatic COVID-19
Sergio Fazio, Flora Affuso, Paolo Bellavite
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 16
Sergio Fazio, Flora Affuso, Paolo Bellavite
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 16
A Literature Review on the Antiviral Mechanism of Luteolin
Peng Lü, Tingrui Zhang, Yali Ren, et al.
Natural Product Communications (2023) Vol. 18, Iss. 4
Open Access | Times Cited: 9
Peng Lü, Tingrui Zhang, Yali Ren, et al.
Natural Product Communications (2023) Vol. 18, Iss. 4
Open Access | Times Cited: 9
Protective effects of Jing-Si-herbal-tea in inflammatory cytokines-induced cell injury on normal human lung fibroblast via multiomic platform analysis
Chien-Hao Wang, Jai‐Sing Yang, Chao‐Jung Chen, et al.
Tzu Chi Medical Journal (2024) Vol. 36, Iss. 2, pp. 152-165
Open Access | Times Cited: 2
Chien-Hao Wang, Jai‐Sing Yang, Chao‐Jung Chen, et al.
Tzu Chi Medical Journal (2024) Vol. 36, Iss. 2, pp. 152-165
Open Access | Times Cited: 2
Antiviral activity of luteolin against porcine epidemic diarrhea virus in silico and in vitro
Jieru Wang, Xiaoyu Zeng, Jiaojiao Gou, et al.
BMC Veterinary Research (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Jieru Wang, Xiaoyu Zeng, Jiaojiao Gou, et al.
BMC Veterinary Research (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection
Xianfang Liu, Longquan Lou, Lei Zhou
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 14
Xianfang Liu, Longquan Lou, Lei Zhou
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 14
The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion
Ting‐Hsu Chen, May‐Jywan Tsai, Chun‐Sheng Chang, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 42-54
Open Access | Times Cited: 13
Ting‐Hsu Chen, May‐Jywan Tsai, Chun‐Sheng Chang, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 42-54
Open Access | Times Cited: 13
Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS‐CoV‐2
Rania Hamdy, Ahmed Mostafa, Noura M. Abo Shama, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2921-2939
Open Access | Times Cited: 12
Rania Hamdy, Ahmed Mostafa, Noura M. Abo Shama, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2921-2939
Open Access | Times Cited: 12
Recruitment of chalcone's potential in drug discovery of anti‐SARS‐CoV ‐2 agents
Mehdi Valipour
Phytotherapy Research (2022) Vol. 36, Iss. 12, pp. 4477-4490
Open Access | Times Cited: 11
Mehdi Valipour
Phytotherapy Research (2022) Vol. 36, Iss. 12, pp. 4477-4490
Open Access | Times Cited: 11
Interleukin‐6 inhibitory effect of natural product naringenin compared to a synthesised monoclonal antibody against life‐threatening COVID‐19
Melika AmeliMojarad, Mandana AmeliMojarad
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Closed Access | Times Cited: 4
Melika AmeliMojarad, Mandana AmeliMojarad
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Closed Access | Times Cited: 4
Baicalin Targets HSP70/90 to Regulate PKR/PI3K/AKT/eNOS Signaling Pathways
Yinzhu Hou, Zuqing Liang, Luyu Qi, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1432-1432
Open Access | Times Cited: 8
Yinzhu Hou, Zuqing Liang, Luyu Qi, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1432-1432
Open Access | Times Cited: 8
Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome
Yuyun Li, Yan Wu, Siyan Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113946-113946
Open Access | Times Cited: 8
Yuyun Li, Yan Wu, Siyan Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113946-113946
Open Access | Times Cited: 8
